HUMATE-P® - Key Publications | CSL Behring Medical Affairs

Have a Question? Use Our New Chat Feature! Chat with our Medical Information Specialists by clicking on the Chat with us now available in the lower right corner of this screen.

Product Information	Educational Materials	Conferences and Events	Key Publications

Von Willebrand Disease Publications

Safety of a pasteurized plasma-derived Factor VIII and von Willebrand factor concentrate: analysis of 33 years of pharmacovigilance data

Tap Image to view Graphical Abstract

P. Kouides, et al, Wiley 2017
Request | Ask a Question | View Article

Pharmacokinetics, efficacy and safety of Humate-P® in von Willebrand disease

Dobrkovska, A et al, Haemophilia 1998
Request | Ask a Question | View Article

von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease

Gill JC, et all. Haemophilia 2011
Request | Ask a Question | View Article

von Willebrand factor/factor VIII concentrate (Haemate P) dosing based on pharmacokinetics: a prospective multicenter trial in elective surgery

Lethagen, S. et al J Thromb Haemost. 2007
Request | Ask a Question | View Article

Von Willebrand Disease Posters

Pasteurized plasma-derived VWF/FVIII concentrate (Humate P): long-term prophylaxis in von Willebrand disease

View Poster

Please see full prescribing information for HUMATE-P

Safety of a pasteurized plasma-derived Factor VIII and von Willebrand factor concentrate: analysis of 33 years of pharmacovigilance data

View Poster

Please see full prescribing information for HUMATE-P

Intermittent prophylaxis for heavy menstrual bleeding in von Willebrand disease

View Poster

Please see full prescribing information for HUMATE-P